Context Therapeutics INC Form 4 insider transactions

Director Linda West of Context Therapeutics Inc. [CNTX] was granted stock options to purchase 25,000 shares of common stock on June 13, 2024.

Director Richard J. Berman acquired stock options in Context Therapeutics Inc. on June 13, 2024.

Jennifer Lynn Minai-Azary, CFO of Context Therapeutics Inc., acquired stock options for 160,115 shares on March 21, 2024.

Alex C. Levit, Chief Legal Officer and Corporate Secretary of Context Therapeutics Inc., acquired stock options for 153,515 shares on March 21, 2024.

Context Therapeutics CEO Martin A. Lehr was granted stock options to purchase 291,402 shares of common stock on March 21, 2024.